We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Biomedicine

Search Results

Showing 401-412 of 412 results

  1. Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers

    A new, orally active angiotensin converting enzyme (ACE) inhibitor, CGS 16617, has been evaluated in normotensive subjects during acute and prolonged...

    G. Waeber, M. Burnier, ... H. R. Brunner in European Journal of Clinical Pharmacology
    Article 01 November 1989

  2. Trade Names

    Paul Turner, Glyn N. Volans, Heather M. Wiseman in Drugs Handbook 1990–1991
    Chapter 1990

  4. Approved Names

    Paul Turner, Glyn N. Volans, Heather M. Wiseman in Drugs Handbook 1990–1991
    Chapter 1990

  5. Modulation of gentamicin nephrotoxicity by chronic inhibition of angiotensin-I-converting enzyme in rat

    Perindopril, a new specific and potent inhibitor of angiotensin-I-converting enzyme, was used to evaluate the possible participation of inhibition of...

    J. P. Morin, N. Thomas, ... J. P. Fillastre in Archives of Toxicology
    Article 01 February 1989

  6. Enalapril and hydrochlorothiazide in hypertensive Africans

    The antihypertensive efficacy both of angiotensin converting enzyme (ACE) inhibitors and thiazide diuretics has been claimed to be influenced by...

    A. A. Ajayi, E. A. Oyewo, ... A. Akinsola in European Journal of Clinical Pharmacology
    Article 01 May 1989

  7. Pharmacokinetics of Angiotensin Converting Enzyme Inhibitors in Plasma and Tissue Using Radioinhibitor Binding and Displacement Assays

    Angiotensin converting enzyme (ACE) inhibitors now have an important place in the treatment of hypertension and congestive cardiac failure1-3. After...
    C. I. Johnston, B. Jackson, ... M. Kozhuki in Kinins V
    Chapter 1989

  8. Safety and tolerance of single oral doses of trandolapril (RU 44.570), a new angiotensin converting enzyme inhibitor

    The safety and tolerance of single oral doses of a new angiotensin converting enzyme (ACE) inhibitor, trandolapril have been examined in 90 healthy...

    A. Patat, A. Surjus, ... J. Granier in European Journal of Clinical Pharmacology
    Article 01 January 1989

  10. The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients

    We have studied the effects of treatment for one month with perindopril, 4 or 8 mg once daily, in seven hypertensive patients. Blood pressure was...

    K. R. Lees, J. L. Reid in European Journal of Clinical Pharmacology
    Article 01 September 1987

  11. Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A

    A new, orally active angiotensin converting enzyme (ACE) inhibitor, CGS 14824A, was evaluated in 12 healthy male volunteers. Two groups each of 6...

    G. Waeber, T. Fasanella d'Amore, ... H. R. Brunner in European Journal of Clinical Pharmacology
    Article 01 November 1987

  12. Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes

    The effect of the angiotensin converting enzyme inhibitor, perindopril, on autonomic function was assessed in a double blind, placebo controlled,...

    A. A. Ajayi, K. R. Lees, J. L. Reid in European Journal of Clinical Pharmacology
    Article 01 March 1986
Did you find what you were looking for? Share feedback.